𝔖 Bobbio Scriptorium

✦ LIBER ✦

After lumpectomy, overall survival is similar with tamoxifen alone compared with tamoxifen plus radiotherapy in elderly women with early stage breast cancer

Book ID: 119232874
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 135 KB
Volume: 9
Category: Article
ISSN: 1744-2249
DOI: 10.1016/j.ehbc.2004.11.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy plus tamoxifen reduces loca

Radiotherapy plus tamoxifen reduces local recurrence rates in older women with early breast cancer compared with tamoxifen alone

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Switching to exemestane after 2–3 years

Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.

✍ Christina Davies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB